Literature DB >> 6802883

The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression.

J J Mann, A Frances, R D Kaplan, J Kocsis, E D Peselow, S Gershon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6802883     DOI： 10.1097/00004714-198202000-00008

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

1.  Effects of depression, cigarette smoking, and age on monoamine oxidase B in amygdaloid nuclei.

Authors:  Beata Karolewicz; Violetta Klimek; He Zhu; Katalin Szebeni; Emily Nail; Craig A Stockmeier; Laurel Johnson; Gregory A Ordway
Journal:  Brain Res       Date:  2005-05-10       Impact factor: 3.252

2.  Cognitive effects of L-deprenyl in Alzheimer's disease.

Authors:  P N Tariot; T Sunderland; H Weingartner; D L Murphy; J A Welkowitz; K Thompson; R M Cohen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 4.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.

Authors:  V Glover; C J Pycock; M Sandler
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

6.  Tyramine pressor sensitivity changes during deprenyl treatment.

Authors:  T Sunderland; E A Mueller; R M Cohen; D C Jimerson; D Pickar; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.